Behavioral Migraine Management Modifies Behavioral and Cognitive Coping in People With Migraine
Objective This is a secondary analysis of a randomized clinical trial which aims to examine changes in cognitive and behavioral responses to migraine with cognitive behavioral treatment for migraine, preventive medication for migraine, and their combination, and the relationship between these change...
Gespeichert in:
| Veröffentlicht in: | Headache 2014-10, Vol.54 (9), p.1470-1483 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1483 |
|---|---|
| container_issue | 9 |
| container_start_page | 1470 |
| container_title | Headache |
| container_volume | 54 |
| creator | Seng, Elizabeth K. Holroyd, Kenneth A. |
| description | Objective
This is a secondary analysis of a randomized clinical trial which aims to examine changes in cognitive and behavioral responses to migraine with cognitive behavioral treatment for migraine, preventive medication for migraine, and their combination, and the relationship between these changes and reductions in migraine‐related disability.
Background
Cognitive behavioral treatment is thought to reduce migraine‐related disability through modifying maladaptive cognitive and behavioral responses to migraine.
Methods
Two hundred thirty‐two people with migraine who did not respond to 5 weeks of optimized acute therapy were randomized into a 2 (beta‐blocker vs placebo) X 2 (behavioral migraine management [BMM] vs no BMM) treatment design. Participants received BMM and/or beta‐blocker dose adjustment for 4 months, and were followed for an additional 12 months. Participants completed measures of catastrophizing, behavioral coping, and migraine‐related disability throughout the study.
Results
Compared to drug therapy only, BMM demonstrated larger decreases in catastrophizing scores (19.16 to 9.89 vs 16.78 to 11.84, P |
| doi_str_mv | 10.1111/head.12426 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1622617229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1613940533</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4286-34d043d61f4fa537d28972e6e36ccb3b58d3b46d941c1614528caf6272b0f9363</originalsourceid><addsrcrecordid>eNqN0U1vEzEQBmALUdG0cOEHoJW4IKRtPf7cPbahbSo1QCmo3CzvejZx2XiDvWnpv2fTtBHigPBlfHjmlUYvIa-BHsDwDudo3QEwwdQzMgLJVC4U0OdkRCnovNCi2CV7Kd1QSoUq1QuyyyQVILUeEXOMc3vru2jbbOpn0fqA2dQGO8MFhj6bds43HlP2h7PBZeNuFnzvb3H4LX2YZT5kn7Fbtphd-36-zXpJdhrbJnz1OPfJt9OTr-NJfvHp7Hx8dJHXghUq58JRwZ2CRjRWcu1YUWqGCrmq64pXsnC8EsqVAmpQICQratsopllFm5Irvk_ebXKXsfu5wtSbhU81tq0N2K2SAcWYAs1Y-R8UeCmo5Hygb_-iN90qhuGQtRoSBVVyUO83qo5dShEbs4x-YeO9AWrWDZl1Q-ahoQG_eYxcVQt0W_pUyQBgA-58i_f_iDKTk6MPT6H5ZsenHn9td2z8YZTmWprrj2dmcnr5_erqEswX_hsWF6gm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1612264065</pqid></control><display><type>article</type><title>Behavioral Migraine Management Modifies Behavioral and Cognitive Coping in People With Migraine</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Seng, Elizabeth K. ; Holroyd, Kenneth A.</creator><creatorcontrib>Seng, Elizabeth K. ; Holroyd, Kenneth A.</creatorcontrib><description>Objective
This is a secondary analysis of a randomized clinical trial which aims to examine changes in cognitive and behavioral responses to migraine with cognitive behavioral treatment for migraine, preventive medication for migraine, and their combination, and the relationship between these changes and reductions in migraine‐related disability.
Background
Cognitive behavioral treatment is thought to reduce migraine‐related disability through modifying maladaptive cognitive and behavioral responses to migraine.
Methods
Two hundred thirty‐two people with migraine who did not respond to 5 weeks of optimized acute therapy were randomized into a 2 (beta‐blocker vs placebo) X 2 (behavioral migraine management [BMM] vs no BMM) treatment design. Participants received BMM and/or beta‐blocker dose adjustment for 4 months, and were followed for an additional 12 months. Participants completed measures of catastrophizing, behavioral coping, and migraine‐related disability throughout the study.
Results
Compared to drug therapy only, BMM demonstrated larger decreases in catastrophizing scores (19.16 to 9.89 vs 16.78 to 11.84, P < .001) and increases in number of positive coping strategies (proactive: 1.09 to 1.90 vs 1.16 to 1.09, P < .001; anticipatory: 0.19 to 0.69 vs 0.10 to 0.08, P < .001; migraine management: 0.14 to 0.36 vs 0.04 to 0.04, P < .001) at the end of the follow‐up period. Decreases in catastrophizing were associated with a larger BMM effect on migraine‐related disability (P = .036).
Conclusions
This study demonstrated that BMM modified important cognitive and behavioral factors postulated to be mechanisms of cognitive behavioral treatments for migraine.</description><identifier>ISSN: 0017-8748</identifier><identifier>EISSN: 1526-4610</identifier><identifier>DOI: 10.1111/head.12426</identifier><identifier>PMID: 25041577</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adaptation, Psychological ; Adrenergic beta-Antagonists - therapeutic use ; Adult ; behavioral treatment ; Catastrophization - psychology ; catastrophizing ; cognitive behavioral therapy ; Cognitive Therapy - methods ; coping ; Double-Blind Method ; Female ; Headaches ; Humans ; Male ; Medical treatment ; Middle Aged ; Migraine ; Migraine Disorders - psychology ; Migraine Disorders - therapy ; psychological factor</subject><ispartof>Headache, 2014-10, Vol.54 (9), p.1470-1483</ispartof><rights>2014 American Headache Society</rights><rights>2014 American Headache Society.</rights><rights>Copyright © 2014 American Headache Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4286-34d043d61f4fa537d28972e6e36ccb3b58d3b46d941c1614528caf6272b0f9363</citedby><cites>FETCH-LOGICAL-c4286-34d043d61f4fa537d28972e6e36ccb3b58d3b46d941c1614528caf6272b0f9363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhead.12426$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhead.12426$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25041577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seng, Elizabeth K.</creatorcontrib><creatorcontrib>Holroyd, Kenneth A.</creatorcontrib><title>Behavioral Migraine Management Modifies Behavioral and Cognitive Coping in People With Migraine</title><title>Headache</title><addtitle>Headache: The Journal of Head and Face Pain</addtitle><description>Objective
This is a secondary analysis of a randomized clinical trial which aims to examine changes in cognitive and behavioral responses to migraine with cognitive behavioral treatment for migraine, preventive medication for migraine, and their combination, and the relationship between these changes and reductions in migraine‐related disability.
Background
Cognitive behavioral treatment is thought to reduce migraine‐related disability through modifying maladaptive cognitive and behavioral responses to migraine.
Methods
Two hundred thirty‐two people with migraine who did not respond to 5 weeks of optimized acute therapy were randomized into a 2 (beta‐blocker vs placebo) X 2 (behavioral migraine management [BMM] vs no BMM) treatment design. Participants received BMM and/or beta‐blocker dose adjustment for 4 months, and were followed for an additional 12 months. Participants completed measures of catastrophizing, behavioral coping, and migraine‐related disability throughout the study.
Results
Compared to drug therapy only, BMM demonstrated larger decreases in catastrophizing scores (19.16 to 9.89 vs 16.78 to 11.84, P < .001) and increases in number of positive coping strategies (proactive: 1.09 to 1.90 vs 1.16 to 1.09, P < .001; anticipatory: 0.19 to 0.69 vs 0.10 to 0.08, P < .001; migraine management: 0.14 to 0.36 vs 0.04 to 0.04, P < .001) at the end of the follow‐up period. Decreases in catastrophizing were associated with a larger BMM effect on migraine‐related disability (P = .036).
Conclusions
This study demonstrated that BMM modified important cognitive and behavioral factors postulated to be mechanisms of cognitive behavioral treatments for migraine.</description><subject>Adaptation, Psychological</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>behavioral treatment</subject><subject>Catastrophization - psychology</subject><subject>catastrophizing</subject><subject>cognitive behavioral therapy</subject><subject>Cognitive Therapy - methods</subject><subject>coping</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Headaches</subject><subject>Humans</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Migraine</subject><subject>Migraine Disorders - psychology</subject><subject>Migraine Disorders - therapy</subject><subject>psychological factor</subject><issn>0017-8748</issn><issn>1526-4610</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0U1vEzEQBmALUdG0cOEHoJW4IKRtPf7cPbahbSo1QCmo3CzvejZx2XiDvWnpv2fTtBHigPBlfHjmlUYvIa-BHsDwDudo3QEwwdQzMgLJVC4U0OdkRCnovNCi2CV7Kd1QSoUq1QuyyyQVILUeEXOMc3vru2jbbOpn0fqA2dQGO8MFhj6bds43HlP2h7PBZeNuFnzvb3H4LX2YZT5kn7Fbtphd-36-zXpJdhrbJnz1OPfJt9OTr-NJfvHp7Hx8dJHXghUq58JRwZ2CRjRWcu1YUWqGCrmq64pXsnC8EsqVAmpQICQratsopllFm5Irvk_ebXKXsfu5wtSbhU81tq0N2K2SAcWYAs1Y-R8UeCmo5Hygb_-iN90qhuGQtRoSBVVyUO83qo5dShEbs4x-YeO9AWrWDZl1Q-ahoQG_eYxcVQt0W_pUyQBgA-58i_f_iDKTk6MPT6H5ZsenHn9td2z8YZTmWprrj2dmcnr5_erqEswX_hsWF6gm</recordid><startdate>201410</startdate><enddate>201410</enddate><creator>Seng, Elizabeth K.</creator><creator>Holroyd, Kenneth A.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201410</creationdate><title>Behavioral Migraine Management Modifies Behavioral and Cognitive Coping in People With Migraine</title><author>Seng, Elizabeth K. ; Holroyd, Kenneth A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4286-34d043d61f4fa537d28972e6e36ccb3b58d3b46d941c1614528caf6272b0f9363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adaptation, Psychological</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>behavioral treatment</topic><topic>Catastrophization - psychology</topic><topic>catastrophizing</topic><topic>cognitive behavioral therapy</topic><topic>Cognitive Therapy - methods</topic><topic>coping</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Headaches</topic><topic>Humans</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Migraine</topic><topic>Migraine Disorders - psychology</topic><topic>Migraine Disorders - therapy</topic><topic>psychological factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seng, Elizabeth K.</creatorcontrib><creatorcontrib>Holroyd, Kenneth A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Headache</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seng, Elizabeth K.</au><au>Holroyd, Kenneth A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Behavioral Migraine Management Modifies Behavioral and Cognitive Coping in People With Migraine</atitle><jtitle>Headache</jtitle><addtitle>Headache: The Journal of Head and Face Pain</addtitle><date>2014-10</date><risdate>2014</risdate><volume>54</volume><issue>9</issue><spage>1470</spage><epage>1483</epage><pages>1470-1483</pages><issn>0017-8748</issn><eissn>1526-4610</eissn><abstract>Objective
This is a secondary analysis of a randomized clinical trial which aims to examine changes in cognitive and behavioral responses to migraine with cognitive behavioral treatment for migraine, preventive medication for migraine, and their combination, and the relationship between these changes and reductions in migraine‐related disability.
Background
Cognitive behavioral treatment is thought to reduce migraine‐related disability through modifying maladaptive cognitive and behavioral responses to migraine.
Methods
Two hundred thirty‐two people with migraine who did not respond to 5 weeks of optimized acute therapy were randomized into a 2 (beta‐blocker vs placebo) X 2 (behavioral migraine management [BMM] vs no BMM) treatment design. Participants received BMM and/or beta‐blocker dose adjustment for 4 months, and were followed for an additional 12 months. Participants completed measures of catastrophizing, behavioral coping, and migraine‐related disability throughout the study.
Results
Compared to drug therapy only, BMM demonstrated larger decreases in catastrophizing scores (19.16 to 9.89 vs 16.78 to 11.84, P < .001) and increases in number of positive coping strategies (proactive: 1.09 to 1.90 vs 1.16 to 1.09, P < .001; anticipatory: 0.19 to 0.69 vs 0.10 to 0.08, P < .001; migraine management: 0.14 to 0.36 vs 0.04 to 0.04, P < .001) at the end of the follow‐up period. Decreases in catastrophizing were associated with a larger BMM effect on migraine‐related disability (P = .036).
Conclusions
This study demonstrated that BMM modified important cognitive and behavioral factors postulated to be mechanisms of cognitive behavioral treatments for migraine.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>25041577</pmid><doi>10.1111/head.12426</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0017-8748 |
| ispartof | Headache, 2014-10, Vol.54 (9), p.1470-1483 |
| issn | 0017-8748 1526-4610 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1622617229 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Adaptation, Psychological Adrenergic beta-Antagonists - therapeutic use Adult behavioral treatment Catastrophization - psychology catastrophizing cognitive behavioral therapy Cognitive Therapy - methods coping Double-Blind Method Female Headaches Humans Male Medical treatment Middle Aged Migraine Migraine Disorders - psychology Migraine Disorders - therapy psychological factor |
| title | Behavioral Migraine Management Modifies Behavioral and Cognitive Coping in People With Migraine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A48%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Behavioral%20Migraine%20Management%20Modifies%20Behavioral%20and%20Cognitive%20Coping%20in%20People%20With%20Migraine&rft.jtitle=Headache&rft.au=Seng,%20Elizabeth%20K.&rft.date=2014-10&rft.volume=54&rft.issue=9&rft.spage=1470&rft.epage=1483&rft.pages=1470-1483&rft.issn=0017-8748&rft.eissn=1526-4610&rft_id=info:doi/10.1111/head.12426&rft_dat=%3Cproquest_cross%3E1613940533%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1612264065&rft_id=info:pmid/25041577&rfr_iscdi=true |